274 related articles for article (PubMed ID: 9004724)
21. [Human papilloma virus infection in vaginal condyloma acuminatum].
Tsuji K; Nakamura Y; Mori I; Tanaka M
Rinsho Byori; 2003 Feb; 51(2):93-7. PubMed ID: 12690625
[TBL] [Abstract][Full Text] [Related]
22. [Use of the Digene Hybrid Capture System for identification of the human papillomavirus (HPV-Human Papillomavirus) in women with cervical dysplasia].
Kwaśniewska A; Semczuk M; Sikorski M; Kraczkowski J
Przegl Lek; 1997; 54(12):848-50. PubMed ID: 9591452
[TBL] [Abstract][Full Text] [Related]
23. Concurrent HPV infection in oral and genital mucosa.
Badaracco G; Venuti A; Di Lonardo A; Scambia G; Mozzetti S; Benedetti Panici P; Mancuso S; Marcante ML
J Oral Pathol Med; 1998 Mar; 27(3):130-4. PubMed ID: 9563805
[TBL] [Abstract][Full Text] [Related]
24. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
25. Mass screening for human papillomavirus type 16 infection in infertile couples.
Tanaka H; Karube A; Kodama H; Fukuda J; Tanaka T
J Reprod Med; 2000 Nov; 45(11):907-11. PubMed ID: 11127102
[TBL] [Abstract][Full Text] [Related]
26. Detection of human papilloma virus (HPV) genomes by the primed in situ (PRINS) labelling technique.
Ramael M; Van Steelandt H; Stuyven G; Van Steenkiste M; Degroote J
Pathol Res Pract; 1999; 195(12):801-7. PubMed ID: 10631714
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of human papillomavirus gynecologic infections.
Wick MJ
Clin Lab Med; 2000 Jun; 20(2):271-87, vi. PubMed ID: 10863641
[TBL] [Abstract][Full Text] [Related]
28. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
[TBL] [Abstract][Full Text] [Related]
29. Practical tips for assessment and management of vulvar and vaginal human papillomavirus.
Brucks JA; Jacobs EW
Nurse Pract Forum; 1992 Sep; 3(3):169-76. PubMed ID: 1335318
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
Harnish DG; Belland LM; Scheid EE; Rohan TE
Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
[TBL] [Abstract][Full Text] [Related]
32. [The value of the Pap test in the diagnostic approach to HPV infection of the cervix uteri].
Pozzi M; Atlante M; Mariani L; Marandino F; Martino P; Minimo C; Perrone Donnorso R
Minerva Ginecol; 1995; 47(7-8):301-4. PubMed ID: 8559440
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
[TBL] [Abstract][Full Text] [Related]
34. Primary care of HPV management in HIV-infected women.
Dole PJ
Nurse Pract Forum; 2001 Dec; 12(4):214-22. PubMed ID: 11889689
[TBL] [Abstract][Full Text] [Related]
35. [Use of the hybridization in situ method in the detection of human papillomaviruses in female genital tumor tissue].
Milosević V; Durisić S; Sljapić N; Tesić M; Mihajlović O
Med Pregl; 1993; 46(11-12):421-4. PubMed ID: 7997197
[TBL] [Abstract][Full Text] [Related]
36. Clinical and epidemiological correlations between the infection with HPV 16 and HPV 18 and female cervical lesions.
Stoian M; Repanovici R; Corniţescu F
Rom J Virol; 1995; 46(3-4):161-70. PubMed ID: 9179967
[TBL] [Abstract][Full Text] [Related]
37. [Papillomavirus infection in healthy women from St.Petersburg].
Aleksandrova IuN; Lyshchëv AA; Safronnikova NR; Rudenko VI; Imianitov EN; Khnason KP
Vopr Onkol; 2000; 46(2):175-9. PubMed ID: 10853416
[TBL] [Abstract][Full Text] [Related]
38. Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women.
Gagnon S; Hankins C; Tremblay C; Forest P; Pourreaux K; Coutlée F;
J Infect Dis; 2004 Nov; 190(9):1575-85. PubMed ID: 15478061
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with human papillomavirus infection in women encountered in community-based offices.
Reed BD; Zazove P; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT
Arch Fam Med; 1993 Dec; 2(12):1239-48. PubMed ID: 8130905
[TBL] [Abstract][Full Text] [Related]
40. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
